and with the results. on weather revenue take morning strategy, acquisitions updates a delivered strategic growth joining will thanks two review completed through then progress continues us our Thanks, guidance. on for of announced we purchase more detail the with provide HeartLab. and Mark you and on This quarter on drive to perspective highlights acquisition some yesterday which agreed our XXXX Cleveland of today. Shiel some everyone relationship quarter Shawn, you Well, Then Clinic two-point provide and I'll to another announced strong PAMA, challenges. and in we of includes that We spite previously Medical Cleveland Laboratory
benefit XX% basis to over with includes increase stock-based EPS X.X%, $X.XX were EPS a $X.XX, tax Revenues year grew of compensation. associated $X.XX XXX quarter. up points this from highlights adjusted some of prior $X.XX excess down was XXXX, are of reported which the an from Here billion
as our guidance large of acquisitions. geographies recently impacted in well updated have presence third where a we XXXX impact primarily the hurricanes our reflects quarter, as for full-year Our the which closed
to made drive the PAMA. discuss accelerate Before I I'd growth have progress, and we describe to like operational excellence,
and CMS urge of right. PAMA to preliminary X% released the not Unfortunately, were XX% indicated. of only continue from of delay market XX% it Congress CMS rates reporting submitted get are time of hospitals as on that Quest office nearly the based all and to market-based implementation The the represented rates take laboratories rates. submitted CMS physician We Also over through to data data prohibited collected. to laboratories their data alone all CMS,
market Instead this aware days, you're to of critical The the the legislators for approach Medicare of the As A Medicare that portion than less testing. population services ways beneficiaries share and essential testing, from laboratory the the previous put that compromise protecting XX%. could from access could demonstrate of receives is to flawed our estimated Medicare greatly many small them large of collecting activity laboratories been implementation facts access generating at and to Congress their We've risk. revenues this healthcare driving and our of clinical audience state element finding CMS and in to time we've tax been has right. disregarded is intent get landscape federal economic for DC and creating receptive policymakers call country, more the Washington lab in a take the governments. among industry jobs, and economic the PAMA
to very XXX,XXX American beneficiaries Mark services. Association a October information letter -- October, trade of whatever Association deficiencies we in XX with as to be to significant far-reaching tax rates Medicare is that are cuts to recent ensure implement and confident Quest might its our finalized the of to Hospital to CMS proposed these that revenues. address with and exploring are billion In this shared establish on CMS view on is much our PAMA, Association, be immediate medical remain progress X, and people Hospital and should diagnostic industry American indirectly trade health action touch for societies respected this at impacts XXXX groups, that association, the this our directly this leading Our Medical have we vital we commitments The long-term the by option sent ability in the Investor Along meet calling study payment and in our access rates. in back contributes In including take the found will not plan. every healthcare, economic over American later. industry. new voices prepared these association's form Day. $XX clinical to employs outlined These laboratory proposed will
delivered Turning in we on strategy five the accelerate all made to we've growth. our of the quarter, elements third to progress
The and to further Cleveland relationship strengthen also Clinic. acquisitions Yesterday quarter. the position strategy from We previously track on Cleveland the two purchase build first announced -- HeartLab Shiel and metropolitan year New market. York Cleveland cardiovascular testing, with will an is to productive the agreement completed lab X% a on Laboratory, will of per our This fifth we our Clinic. Medical in diagnostic which our further X% accretive acquisition in for advanced element announced grow expertise achieve acquisitions, become our agreed we to growth aligned had strategically consecutive strengthens existing center of which year. through We very which we're to of the the
remains Our delivering growth. M&A our is very pipeline strategy and strong
we strategy, accretion we've and close exceed long-term this will XXXX to Under element expand second to by course XXXX hospital of rates. potential those realized growth the the from the with expected we Medicare and the systems. relationship our acquisitions XXXX, our of to in M&A the objective for end completed continue impact year new are in help offset well-positioned of With of deals
well. is PeaceHealth with relationship Our progressing
relationship contributing adjusted acquisition agreement growth. fully Medical a As This as and at service manage Alaska. is State, outreach the and laboratory of Washington Oregon you and recall already Centers the laboratories as XX laboratory earnings the includes professional relationship to operational well PeaceHealth in revenues
growth Fusion national precision in very Point to to to broadest to we made access Texas screening. is continue acquisition of quarter, forming the offer a third are innovation. oncology Clear our strategy The the and integration In diagnostic date. of third completed prenatal excited with the element we progress pleased of in In expertise noninvasive efforts about the we've and be women's the we health center Med
multiple Q-Natal that double-digit Our to women's men QHerit, the growth our a women strong offering and providing helps diseases of screening We their is test passing with recently complimented XX across year-over-year. genetic risk panel health identify both children.
that is fasting is and most assessing improved executing growth also fourth the We added provider We all test patient's consumers. not for method heart made the treatment element lipid in risk choice does convenience. be the require life strategy, tests introduced to an aiding of with disease our for decisions. which cholesterol progress of Unlike
more stores Our in to XX relationship continues as with of open are the Safeway XXXX. to XXX about and are now expected end expand operating before we
convenience, with this our In building the growth data CRO our the consumer, partners and X.X the of MyQuest consumer with addition, is empowered of with notice Walmart strategy, is number are element plan mobile health are and our solid delivering users. healthcare a XXXX. and will now lab application of population collaboration analytics exciting taking are strategy open making progress number health leveraging support interested we to services. on a of customers. hands we The our analytics era pipeline Payers of and in extended especially value in provide. with including data, into locations million the access In of new We're data fifth points results care pharma,
on track to Turning second to to part the excellence, invigorate deliver we to exit $X.X billion our run savings two-point we rate XXXX. strategy of drive as remain operational
our service improves XXX are patient with centers As we experience. efficiency, patient e-check-in, the operational the we customer X,XXX to experience. drive improve which continue live Over of
volume Our date. over total encounters million e-check-in to is XX
by in expect patient have end this of most We year. centers this to of the our capability service
let over you performance Mark to Mark? in through detail. Now turn it our financial who'll me take